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Background: Response surface methodology by Box–Behnken design employing the multivariate approach
enables substantial improvement in the method development using fewer experiments, without wastage of large
volumes of organic solvents, which leads to high analysis cost. This methodology has not been employed for
development of a method for analysis of atorvastatin calcium (ATR-Ca).
Results: The present research study describes the use of in optimization and validation of a new microwell-based
UV-Visible spectrophotometric method of for determination of ATR-Ca in its tablets. By the use of quadratic
regression analysis, equations were developed to describe the behavior of the response as simultaneous
functions of the selected independent variables. Accordingly, the optimum conditions were determined which
included concentration of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), time of reaction and temperature.
The absorbance of the colored-CT complex was measured at 460 nm by microwell-plate absorbance reader.
The method was validated, in accordance with ICH guidelines for accuracy, precision, selectivity and linearity
(r² = 0.9993) over the concentration range of 20–200 μg/ml. The assay was successfully applied to the analysis of
ATR-Ca in its pharmaceutical dosage forms with good accuracy and precision.
Conclusion: The assay described herein has great practical value in the routine analysis of ATR-Ca in quality
control laboratories, as it has high throughput property, consumes minimum volume of organic solvent thus it
offers the reduction in the exposures of the analysts to the toxic effects of organic solvents, environmentally
friendly "Green" approach) and reduction in the analysis cost by 50-fold.
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Atorvastatin calcium (ATR-Ca); [(R-(R*,R*)]-2-(4-fluoro-
phenyl)-β,δ,dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenyl-
amino)-carbonyl]-1H-pyrrole-1-heptanoic acid calcium
salt (Figure 1), is a second generation synthetic 3-hydroxy-
3-methylglutaryl-coenzyme A (HMG-CoA) reductase
inhibitor [1]. It exerts its action by specifically inhibiting
the HMG-CoA reductase, the enzyme that catalyzes the
conversion of HMG-CoA to mevolanate, which is the* Correspondence: idarwish@ksu.edu.sa
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reproduction in any medium, provided the orearly rate-limiting step in the biosynthesis of cholesterol
in the body. ATR-Ca decreases the amount of LDL-
cholesterol in the blood and also reduces blood levels of tri-
glycerides and slightly increases levels of HDL-cholesterol.
ATR-Ca is the most efficient and frequently prescribed drug
for the treatment of hypercholesterolaemia [2].
Response surface methodology (RSM) is a statistical
technique used for the development and optimization of
complex processes [3,4]. It was selected and used to find
the optimum spectrophotometric conditions for analysis
of atorvastatin. The technique has several advantages
over conventional experimental or optimization methods
in which one variable at a time is used. RSM provides al Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and











Figure 1 The chemical structure of Atorvastatin Calcium
(ATR-Ca).
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approach because a small number of experiments are
performed for monitoring the interaction of the inde-
pendent variables on the response. In conventional
optimization, the increase in the number of experiments
necessary to carry out the research, leads to an increase
in time and expenses as well as an increase in the
utilization of reagents and materials for experiments.
The equation of the model easily clarifies the effects
for binary combinations of the independent variables.
Many types of response surface designs are used for
optimization like Central composite, Doehlert, and Box–
Behnken. Box–Behnken design is preferable to the Cen-
tral composite and Doehlert designs because it requires
fewer test runs and is rotatable. A design is rotatable
only when the experiments are roughly situated on a
(hyper) sphere. By adequate selection of the number of
centre points, it is possible to arrange that the precision
of the response of a predicted design is similar over
the whole domain. Such a design is said to have uni-
form precision.
Box–Behnken design is advantageous because it does
not contain any points at the extremes of the cubic
region created by the two-level factorial level combina-
tions [3-5]. In the present investigation the Box Behnken
design was selected and used to optimize, validate and
analyze the atorvastatin spectrophotometrically, because
the design provides three levels for each factor and
requires fewer runs in the three-factor case than Central
composite and Doehlert design.
In general, UV-visible spectrophotometry is the most
widely used technique in pharmaceutical analysis because
of its inherent simplicity and wide availability in mostquality control laboratories [6-10]. However, the UV-
visible spectrophotometric methods that have been
reported for determination of ATR-Ca in its pharmaceut-
ical formulations [11-17] suffer from major drawbacks.
These drawbacks include decreased selectivity due to
measuring the native light absorption of ATR-Ca in the
blue-shifted ultraviolet region, which might be subjected
to interferences [13], employment of multiple-steps of
non-selective oxidation reactions [14-16], and tedious
liquid-liquid extraction procedures using large volumes
of organic solvents in the methods based on formation
of ion-pair associates [17]. Microwell based automated
spectrophotometric method for determination of ATR-Ca
using colored charge-transfer (CT) complex has been
developed as alternative for the conventional spectro-
photometric technique [18]. Moreover, the conventional
methods suffer from the consumption of large volumes of
organic solvents, which leads to high analysis cost, and
more importantly, the incidence of exposure of the ana-
lysts to the toxic effects of the organic solvents [19-23].
These days, there is an urge in scientific community for
the improvement in existing analytical methods in such a
way that the developed approach includes both the posi-
tive traits (selectivity and sensitivity) of the traditional
methods as well as the environmentally friendly "Green"
approach, in which the amount of hazardous reagents
used and chemical waste generated during analysis should
be minimal.
Considering the variability of spectrophotometric con-
ditions used in analysis of atorvastatin by CT reaction,
need for cost reductions and need for environmentally
friendly "Green" approach in routine pharmaceutical
analysis, the objective of this research was to optimize
and validate CT based reaction of ATR-Ca, and its
employment in the optimization of simple and reliable
automated microwell based spectrophotometric assay
with high throughput analysis. A multivariate approach
was adopted as an analytical tool to study the effect of
different parameters and to improve spectrophotometric
conditions for the analysis of ATR-Ca.Methods
Apparatus
Microwell-plate absorbance reader (ELx 808, Bio-Tek
Instruments Inc. Winooski, USA) was used for all the
measurements in 96-microwell plates. 96-Microwell
plates were a product of Corning/Costar Inc. (Cambridge,
USA). Finnpipette adjustable 8–channel-pipette was
obtained from Sigma Chemical Co. (St. Louis, MO, USA).Chemicals and dosage forms
ATR-Ca was obtained from Pfizer Inc. (New York,
USA). DDQ was obtained from (Merck, Germany).






DDQ % A 0.06 0.25
Time Minutes B 1 6
Temperature °C C 25 37
Figure 2 Mechanism of CT reaction of ATR-Ca with DDQ.
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tablets (INTAS Pharmaceuticals, India) labeled to con-
tain 10 mg ATR-Ca were obtained from the local market
and from India.
Preparation of standard and tablet solutions
Preparation of stock standard solutions
Into a 5-ml calibrated flask, 10 mg of ATR-Ca was
accurately weighed, dissolved in 2 ml methanol, and
completed to volume with the same solvent. This
stock solution was diluted with methanol to obtain the
suitable concentrations that lie in the linear range of
the assay.
Preparation of DDQ solutions
Into a 5-ml calibrated flask, 8 mg of DDQ was accur-
ately weighed, dissolved in 2 ml methanol, and com-
pleted to volume with the same solvent.
Preparation of tablet sample solutions
Twenty tablets were weighed and finely powdered.
A quantity of the powder equivalent to 20 mg of ATR-
Ca was transferred into a 10-ml calibrated flask, dis-
solved in 4 ml methanol, swirled and sonicated for
5 min, completed to volume with the methanol, shaken
well for 15 min, and filtered. The first portion of the fil-
trate was rejected, and a measured volume of the filtrate
was diluted quantitatively with methanol to yield
the suitable concentrations that lie in the linear range of
the assay.
Analytical procedure
Accurately measured aliquots (100 μl) of the standard or
sample solution containing varying amounts of ATR-Ca
(20–200 μg) were transferred into wells of 96-microwell
assay plates. One hundred microliters of DDQ solution
(0.16%, w/v) was added, and the reaction was allowed to
proceed at (31 ± 1°C) for 3.5 min. The absorbances of
the resulting solutions were measured at 460 nm by the
microwell-plate reader. Blank wells were treated simi-
larly except 100 μl of methanol was used instead of sam-
ple, and the absorbances of the blank wells were
subtracted from those of the other wells.
Optimization of experimental conditions
Box–Behnken experimental design
A response surface statistical experimental design was
used to optimize the concentration of DDQ, time,
and temperature. This design was based on a 33 factorial
design, three replicates of the central run, leading to
15 sets of experiments, enabling each experimental
response to be optimized. The responses were investi-
gated using a Box–Behnken statistical experimental
design. The optimization process involves evaluating theresponse of the statistically designed combinations, esti-
mating the coefficients by fitting the experimental data
to the response function, predicting the response of the
fitted model, and checking the adequacy of the model.
All experiments were performed in standard order to
minimize the effects of uncontrolled factors that may
introduce a bias in the response. Before starting an
optimization procedure, it is important to identify the
crucial factors affecting the quality of the derived out-
comes. The levels for the variables were chosen on the
basis of their minimum and maximum effect on
absorbance and also each level has been tested at lower
and higher end. The levels of the three factors evaluated
in this design are listed in (Table 1). A three factor,
Figure 3 Absorption spectrum of (A) ATR-Ca (125 μg/ml) and (B) reaction product of ATR-Ca (125 μg/ml) with DDQ (0.16%, w/v).
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optimization procedure, using the software Design Ex-
pert V 7.1.1. All other factors, for example volume and
detection wavelength were maintained constant. The
quality of the fitted model was expressed by the coeffi-
cient of determination R2, and its statistical significance
was checked by an F-test (analysis of variance) at the
5% significance level. The statistical significance of
the regression coefficients was determined by using the
t-test (only significant coefficients with p-value < 0.05
are included). The optimum processing conditions were
obtained by using graphical and numerical analysis
based on the criteria of the desirability function and the




1 0.06 6.00 31.00 0.99
2 0.16 3.50 31.00 1.63
3 0.06 3.50 37.00 0.95
4 0.25 3.50 37.00 1.85
5 0.16 1.00 37.00 1.46
6 0.16 3.50 31.00 1.61
7 0.06 1.00 31.00 0.94
8 0.06 3.50 25.00 0.94
9 0.16 6.00 37.00 1.73
10 0.25 1.00 31.00 1.52
11 0.16 3.50 31.00 1.65
12 0.16 6.00 25.00 1.69
13 0.25 3.50 25.00 1.79
14 0.16 1.00 25.00 1.47
15 0.25 6.00 31.00 1.91Results and discussion
Design of the proposed assay and strategy for its
development
The proposed assay was designed to employ 96-
microwell assay plate as the CT reaction was carried out
in microwells of the assay plate (200-μl reaction volume)
instead of the conventional volumetric flasks (10,000-μl
volume). The solutions were dispensed by 8-channel
pipette, and the absorbances of the colored CT complex
were measured by microwell-plate absorbance reader
instead of the conventional spectrophotometer.
In the present study, ATR-Ca was selected based on
its therapeutic importance, clinical success, and the
expected electron-donating ability. This selection was
supported by a previous study made by Darwish IA [24],
which demonstrated the excellent electron-donating
property of alkali salts of carboxylic acid pharmaceutical
compounds. Previous studies involving CT reactions
with polyhalo-/polycyanoquinone electron n-acceptors
revealed that DDQ is one of the most efficient rea-
gents in terms of its reactivity [24,25]. Furthermore, its
CT reaction with electron-donating analytes is instant-
aneous [24,26]. For these reasons, DDQ was used as
electron acceptor in the development of the proposed
assay. The 96-microwell design of the proposed assay
was based on the previous success of Darwish et al. [27]
in the utility of this design for determination of some
other pharmaceuticals.Table 3 Analysis of variance of calculated model for
atorvastatin absorbance
Source Absorbance
Mean squares F p-value
Model 0.19 100.37 0.0001
Residual 9.417 × 10-003 - -
R2 0.9945
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The interaction of ATR-Ca with DDQ was allowed to
proceed at room temperature, and the absorption
spectrum of the produced chromogen was recorded.
ATR-Ca gave red colored chromogen showing absorp-
tion maximum at 460 nm (Figure 2 and Figure 3). This
band was attributed to the formation of the radical anion
DDQ- [28], which was probably formed by the disso-
ciation of an original donor-acceptor (D-A) complex:





Further support of this assignment was provided by
the absorption maxima with those of DDQ radical anion
produced by the iodide reduction assay [28]. The dis-
sociation of the (D-A) complex was promoted by the
high ionizing power of the polar solvent and the result-
ing peaks in the absorption spectra of drug-acceptor
reaction mixtures were similar to the maxima of the
radical anions of the acceptors obtained by the iodide
reduction assay [28].
Response surface optimization
The key parameters most influencing on the new
microwell-based spectrophotometric method for the
analysis of ATR-Ca, viz DDQ, time and temperature
were studied for study. The response was measured in
terms of actual factors of absorbance. The results of
experimental runs are summarized in (Table 2). Data
collected from experimental runs were analysed by using
the Design Expert software, version V 7.1.1 and fitted
to nonlinear quadratic models for atorvastatin spectro-
photometric analysis. The model was validated by ana-
lysis of variance (ANOVA). The statistical analysis




tercept 1.63 < 0.0001









Figure 4 Response-surface graphs representing the effect of
DDQ, time and temperature on the responses: (a) Relative
effect of DDQ and Time on atorvastatin absorbance at constant
temperature (b) Relative effect of temperature and DDQ on
atorvastatin absorbance, while keeping time constant
(c) Relative effect of temperature and time on absorbance of













Figure 5 Effect of individual factors DDQ (a) and Time (b) on absorbance by atorvastatin.
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rectly related to the variation of the factors (Table 3).
Student’s t-test was used to determine the significance of
the regression coefficients of the variables. A p-value
below 0.05 indicates the test variable is significant at the
5% level. The results are indicative for good precision
and reliability for the experiments carried out. The
significance of each coefficient is listed in Table 4. The
fitted model equation is:
Absorbance ¼ 1:63þ 0:41Aþ 0:12Bþ 0:011C
þ 0:087ABþ 0:011ACþ 1:00E 02BC
 0:25AA 0:043BBþ 2:56E 03CCTable 5 Quantitative parameters for the analysis of ATR-
Ca by the proposed assay
Parameter Value




LOD (μg/well) a 3.91
LOQ (μg/well) a 11.84
a Each well contained 100 μl of ATR-Ca sample.Interpretation of the results has to start from analysis
of the response surface and study of the Derringer’s de-
sirability function. The optimum conditions for absorb-
ance were also estimated by use of Derringer’s
desirability function [29]
D ¼ d1w1  d2w2  . . . dnwn 1=n
where wi is the weight of the response, n the number of
responses, and di the individual desirability function for
each response. In the actual study all with values were
set equal to 1.
This multiple non linear model resulted in response
surface graphs for absorbance (Figure 4a, 4b and 4c).
Point prediction tool of the software was used to calcu-
late maximum absorbance. Finally the optimum values
for DDQ 0.16% w/v, time 3.5 min and temperature 31°C
resulted in absorbance of 1.63. The optimized values of
these parameters were validated under similar condi-
tions. An average 1.612 of absorbance was produced
under optimized conditions with 99.9% validity. The
above results obtained by use of these conditionssuggested that the response surface predictions were in
good agreement with the experimental results. Therefore,
Box–Behnken statistical design was reliable and effective
in determining the optimum conditions.
Figure 3a shows the effect of time and proportion of
DDQ on absorbance at a constant temperature 31°C. It
is apparent from the figure that absorbance increased
with increasing time and proportion of DDQ. Figure 3b
shows the effect of temperature and proportion of
DDQ on absorbance of atorvastatin at fixed time of
3.5 min, as the DDQ concentration increases there is
significant increase in the absorbance upto a certain
limit whereas increase in temperature enhances the ab-
sorbance. Figure 3c shows the effect of temperature and
time on absorbance of atorvastatin at constant concen-
tration of DDQ at 0.16% w/v however, increase in
temperature increases the absorbance and after a certain
period of time there is slight decrease in absorbance.
Figure 5a and 5b shows effect of individual factors DDQ
and Time on the absorbance and as is evident from
the figures that both these variables have direct effect
on absorbance.
Table 6 Precision and accuracy of the proposed assay at different ATR-Ca concentrations
Concentration (μg/well) Relative standard deviation
Intra-day, n=5 Inter-day, n=5
Found (μg/well) % RSD Found (μg/well) % RSD
80 80.60 ± 1.28 1.59 80.75 ± 0.99 1.24
120 120.5 ± 0.85 0.71 120.34 ± 1.11 0.92
180 181.04 ± 1.93 1.07 180.42 ± 1.37 0.76
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conditions
Linearity and sensitivity
Under the above mentioned optimum reaction condi-
tions using response surface methodology, the calibra-
tion curve for the analysis of ATR-Ca by the proposed
assay was constructed by plotting the absorbances as
a function of the corresponding concentrations. The
regression equation for the results was derived using the
least-squares method. Beer’s law plot (n = 10) was linear
with very small intercept (0.0061) and good correlation
coefficient (0.9993) in the concentration range of 20 –
200 μg/well (100 μl). The limits of detection (LOD) and
quantitation (LOQ) were determined [30] using the for-
mula: LOD or LOQ = κSDa/b, where κ = 3.3 for LOD
and 10 for LOQ, SDa is the standard deviation of the
intercept, and b is the slope. The LOD and LOQ values
were 3.91 and 11.84 μg/well (100 μl), respectively. The
quantitative parameters of the proposed assay are given
in Table 5.
Accuracy and precision
Accuracy of the proposed assay was assessed by analyt-
ical recovery studies. Recovery was determined by the
standard addition method. Known amounts of ATR-Ca
were added to pre-determined drug-containing phar-
maceutical formulation, and then determined by the
proposed assay. The mean analytical recovery was calcu-
lated using five determinations and was found to be
98.74 ± 0.7% to 100.22 ± 1.24% indicating the accuracy
of the proposed assay.
The precisions of the proposed assay were determined
on samples of drug solutions at three concentration
levels for each drug by analyzing 5 replicates of each
sample as a batch in a single assay run. The relative
standard deviations (RSD) did not exceed 1.59% (Table 6)
proving the high precision of the assay for the routineTable 7 Analysis of ATR-Ca in its tablets by the reported and
Tablet Content (% ± SD) a
Proposed method R
Lipitor tablets 99.24 ±1.21
Lipicure–10 tablets 98.89± 1.62
a Values are mean of five determinations ± SD.
b The tabulated values at 95% confidence limit are 2.78 and 6.39, respectively.application in quality control laboratories. This high
level of precision was attributed to response surface
methodology optimized conditions. And the accuracy of
the volumes that have been concomitantly dispensed in
the microwells by multi-channel pipettes, and complete-
ness of the reaction the small volume (200 μl).Application of the proposed assay in the analysis of
pharmaceutical formulations
The commercially available pharmaceutical formulations
of ATR-Ca were subjected to the analysis by the pro-
posed and reported methods [16] and the obtained
results were then statistically compared with each other.
The mean percentage recoveries, relative to the labeled
amounts, obtained by the proposed assay were 99.24 ±
1.21 and 98.89 ± 1.62% for Lipitor and lipicure–10
tablets, respectively (Table 7). In the t- and F-tests, no
significant differences were found between the calculated
and theoretical values of both the proposed and the
reported assays at 95% confidence level. This indicated
similar accuracy and precision in the analysis by the pro-
posed and reported methods.
Conclusion
The present study identified the effect of individual vari-
ables on analysis of ATR-Ca by microwell-based spectro-
photometric assay using Box-Benkhen response surface
methodology. The above results obtained using response
surface predictions were in good agreement with the ex-
perimental results. Therefore, Box–Behnken statistical
design used in determining the optimum experimental
conditions such as concentration of DDQ, temperature
and time was reliable and effective. Using the optimized
conditions, development and validation of microwell
based UV-visible spectrophotometric assay (200-μl reac-
tion volume) instead of the conventional volumetricproposed methods
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mination of ATR-Ca based on its CT reaction with
DDQ reagent. The absorbances were measured by
microwell-plate reader instead of the conventional spec-
trophotometer. The assay described herein offered the
following advantages:
– Reduction in the consumption of organic solvents
(environmentally friendly "Green" approach) in the
CT-based UV-visible spectrophotometric analysis,
accordingly reduction in the exposures of the
analysts to the toxic effects of organic solvents.
– Reduction in the analysis cost by 50-folds which
can be reflected on the price for the finished
dosage forms, thus it can reduce the expenses for
the medications.
– Providing a high throughput analytical methodology
that can facilitate the processing of large number of
samples in a relatively short time. This property was
attributed to the use of multi-channel pipettes for
efficient dispensing of the solutions, carrying out
the analytical reaction in 96-well plates (as reaction
vessels), and measuring the color signals in the
96 wells at ~ 30 seconds by the plate reader.
– The advantages of the proposed assay and in
addition to automation could be reached by
application of Flow Injection Analysis.
– Although the proposed assay was developed and
validated for ATR-Ca, however, it is also anticipated
that the same methodology could be used for
essentially any analyte that can exhibit CT reaction.
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